Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
What the Data Shows The SURMOUNT-1 trial, published in the New England Journal of Medicine in 2022, randomized 2,539 adults with obesity to tirzepatide at 5, 10, or 15 mg weekly or placebo for 72 weeks (3)
Current evidence supports this combination as an effective strategy for comprehensive diabetes management, addressing glycemic control, weight, and cardiovascular risk factors simultaneously
It's essential to consider the balance between benefits and risks, which is a complex task that requires a nuanced approach and often, the expertise of medical professionals
Benefits of GLP-1 Medications for Weight Loss Effective Weight Management GLP-1 medications have been shown to facilitate significant weight loss in clinical trials
